NCT07226180 2026-03-18
Development and Application of Patient-Derived Models of Cancer
Certis Oncology Solutions, Inc
Enrolling by invitation
Clinical Trials
12 trialsNCT04164199 2026-03-16
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
BeOne Medicines
Phase 3 Enrolling by invitation
NCT07474051 2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
NCT06435312 2026-03-13
ziMyG+
UCB Pharma
Phase 3 Enrolling by invitation
NCT05332054 2026-03-12
LTFS
Caribou Biosciences, Inc.
Enrolling by invitation
NCT06506955 2026-03-11
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT06540144 2026-02-27
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Enrolling by invitation
NCT05041309 2026-02-25
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
Gilead Sciences
Enrolling by invitation
NCT07158450 2026-02-25
NOECHO
Skribe Medical
Enrolling by invitation
NCT05303532 2026-02-23
ROSY-D
AstraZeneca
Phase 3 Enrolling by invitation
NCT07116668 2026-02-18
SAFE-3CV
SafeHeal Inc
Phase NA Enrolling by invitation
NCT07417774 2026-02-18
RESTORE LB
NuvOx LLC
Enrolling by invitation